2026 NPPES data Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician NPI 1891959037 M.D.
Verify on CMS →

SARA BOZORG, M.D.

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician in MANCHESTER, New Hampshire. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 454 beneficiaries · Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician avg: 642
Generic prescribing
51%
generic claims · 49% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.0699/100
▲ 15 pts above national avg 83.1 · [object Object]
Industry payments
$352.31
6 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SARA BOZORG, M.D. reported a CMS MIPS final score of 98.0699/100 — above the 83.1 national average — and filed 1,710 Medicare Part D claims in 2023.

98.0699/100
MIPS score · +15 vs avg
2K
Part D claims, 2023
51%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SARA BOZORG, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

98 Top 11% higher than 89% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

SARA BOZORG, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SARA BOZORG, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 07/16/2008

NPI 1891959037

Primary specialty

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician

Rare

37 US NPIs in this specialty

Medicare Part D claims

1,710 166% vs specialty avg

2023 prescription claims

Specialty avg: 642

MIPS final score

98.0699/100 14.96990000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New Hampshire

How Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician compares to other specialties among New Hampshire providers

New Hampshire providers

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician share within New Hampshire

1. Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician share within New Hampshire

Medicare quality performance — MIPS

SARA BOZORG, M.D.'s 2023 MIPS final score plotted against the Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
98.0699/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician) — 98.0699/100 vs national avg 83.1

0%100%National avg83%98.1%
MIPS final score (Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician) — 98.0699/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SARA BOZORG, M.D. appears in the CMS NPPES registry as a Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician provider holding M.D. credentials at 250 RIVER RD, MANCHESTER, NH, 03104, with a listed phone of (603) 668-2020. NPI 1891959037 was issued on 07/16/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOZORG most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,710 prescription claims written by this provider, covering 454 Medicare beneficiaries and totaling roughly $191K in drug spend, split 49% brand-name and 51% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.0699/100 for the 2023 performance year (Quality 86.1398), compared with the national average of 83.1.

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician is a narrow specialty nationwide, with 37 enrolled providers across 15 states and an average of 642 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

250 RIVER RD
MANCHESTER, NH 03104

Provider Details

NPI 1891959037
Specialty Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician
Credentials M.D.
Gender Female
NPI Issued 07/16/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

98.0699
Final Score
Avg: 83.1
86.1398
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where SARA BOZORG, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MAINE EYE CENTER PA
PORTLAND, ME

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SARA BOZORG, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$352

Largest payer

Alcon Vision LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

SARA BOZORG, M.D. — brand share 49.0%
Specialty average (est.)

49% brand-name claims vs 51% generic, on 1,710 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,710
Total Claims
$191K
Total Drug Cost
454
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,689
Total Day Supply
68,556
Brand vs Generic
49% brand / 51% generic
Brand Drug Cost
$156K
Generic Drug Cost
$35K
Antibiotic Claims
35

Patient Demographics

Average Patient Age
75.1 years
Avg HCC Risk Score
1.12
Gender Split
59% female / 41% male
Age Distribution
<65: 39, 65-74: 170, 75-84: 182, 85+: 63

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SARA BOZORG, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisolone Acetate
421
Ofloxacin
273
Ketorolac Tromethamine
264
Fluorometholone
241
Valacyclovir
Valacyclovir Hcl
67
Erythromycin
Erythromycin Base
51
Latanoprost
40
Restasis
Cyclosporine
37
Moxifloxacin
Moxifloxacin Hcl
33
Loteprednol Etabonate
28

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician Overview

How SARA BOZORG, M.D. fits within the Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician landscape nationally.

37
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician Providers in US
15
States with Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician
642
Avg Claims per Provider

SARA BOZORG, M.D.'s 1,710 claims are above the specialty average of 642.

Frequently Asked Questions

What is SARA BOZORG, M.D.'s specialty?
SARA BOZORG, M.D. specializes in Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician and practices in MANCHESTER, New Hampshire. Credentials: M.D..
How much does SARA BOZORG, M.D. prescribe under Medicare Part D?
In 2023, SARA BOZORG, M.D. wrote 1,710 Medicare Part D claims totaling $191K in drug costs for 454 beneficiaries.
What is SARA BOZORG, M.D.'s Medicare quality score?
SARA BOZORG, M.D. has a CMS MIPS Final Score of 98.0699/100 (Quality: 86.1398). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SARA BOZORG, M.D. located?
SARA BOZORG, M.D. is located at 250 RIVER RD, MANCHESTER, NH, 03104. Phone: (603) 668-2020.
What is SARA BOZORG, M.D.'s NPI number?
SARA BOZORG, M.D.'s National Provider Identifier (NPI) is 1891959037, issued on 07/16/2008.
Does SARA BOZORG, M.D. prescribe more brand-name or generic drugs?
SARA BOZORG, M.D.'s prescribing is 49% brand-name and 51% generic drugs by claim count, with $156K in brand drug costs.
How many Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician providers are there in the US?
There are 37 Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician providers across 15 states in the US. The average Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician provider writes 642 Medicare Part D claims per year.
What drugs does SARA BOZORG, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SARA BOZORG, M.D.'s most frequently prescribed drugs include Prednisolone Acetate, Ofloxacin, Ketorolac Tromethamine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SARA BOZORG, M.D. accept Medicare?
SARA BOZORG, M.D. appears in CMS Medicare data with 1,710 Part D claims and 454 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SARA BOZORG, M.D.'s credentials?
SARA BOZORG, M.D.'s NPI is 1891959037 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology